Biodesix Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | -1,406.9% | – | – | |
| – | +5.3% | +1.3% | -0.2% | +7.4% | -1.3% | +0.5% | +0.5% | -2.4% | +2.0% | +0.6% | -0.3% | – | |
| – | +13.3% | +144.2% | -53.9% | +24.4% | -16.5% | -23.2% | +6.9% | +1.3% | +2.1% | +3.7% | -26.5% | – | |
| – | – | – | – | – | – | -212.3% | – | -235.5% | – | -386.7% | – | – | |
| – | -49.0% | -90.9% | +631.5% | -85.7% | +209.1% | -84.5% | -30.7% | -29.5% | +55.2% | +38.5% | +76.4% | – | |
| – | -49.0% | -90.9% | +631.5% | -85.7% | +209.1% | -84.5% | -30.7% | -29.5% | +55.2% | +38.5% | +76.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -193.2% | – | +1,813.8% | -193.7% | – | – | – | – | -163.0% | – | – | – | |
| – | – | – | – | – | +0.0% | -46.2% | – | -100.0% | +25.0% | +0.0% | -80.0% | – | |
| – | +78.8% | -96.4% | +6,387.4% | -99.7% | -225.7% | – | +9,991.8% | -50.7% | -64.6% | +888.7% | -63.1% | – | |
| – | +165.1% | -329.6% | – | -135.2% | – | – | – | -231.9% | – | +176.3% | -32.8% | – | |
| – | – | – | – | – | – | – | – | – | – | -1,630.0% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.